Anapharm, a Contract Research Organisation (CRO) and CataloniaBio member that offers bioanalysis and scientific support services for the pharmaceutical industry, has doubled the size of its laboratory in Barcelona and presented its new corporate image as Anapharm Bioanalytics. All of this, as explains company founder and CEO Dr María Cruz, "is the result of improvements to our services and ongoing international growth in recent years."

Anapharm Bioanalytics has also added two more ABSciex 6500 LC-MS/MS/UPLC instruments to its laboratory and software updates. 

The name change does not affect the legal personality of the existing entity (namely Anapharm Europe S.L.U.) which retains its rights and obligations in all existing legal relationships with third parties as well as the regulatory track record achieved to date including GLP and ANVISA certifications as well as FDA and EU-GCP inspection history.

More information on the new website of Anapharm Bioanalytics.